Predict MiRNA-Disease Association with Collaborative Filtering

Original Article
  • 12 Downloads

Abstract

The era of human brain science research is dawning. Researchers utilize the various multi-disciplinary knowledge to explore the human brain,such as physiology and bioinformatics. The emerging disease association prediction technology can speed up the study of diseases, so as to better understanding the structure and function of human body. There are increasing evidences that miRNA plays a significant role in nervous system development, adult function, plasticity, and vulnerability to neurological disease states. In this paper ,we proposed the novel improved collaborative filtering-based miRNA-disease association prediction (ICFMDA) approach. Known miRNA-disease associations can be viewed as a bipartite network between diseases and miRNAs. ICFMDA defined significance SIG between pairs of diseases or miRNAs to model the preference on the choices of other entities. The collaborative filtering algorithm is further improved by incorporating similarity matrices to enable the prediction for new miRNA or disease without known associations. Potential miRNA-disease associations are scored with the addition of bidirectional recommendation results with low computational cost. ICFMDA achieved a 0.9076 AUC of ROC curve in global leave-one-out cross validation, which outperformed the state-of-the-art models. ICFMDA is a compact and accurate tool for potential miRNA-disease association prediction. We hope that ICFMDA would be useful in future miRNA and brain researches,and achieve better understanding of the nervous system in molecular level, cellular level, cell change process, and thus can support the research of human brain.

Keywords

MiRNA-disease associations Collaborative filtering Computational model 

Notes

Acknowledgments

This work is supported by National Nature Science Foundation of China (61525206, 61671196,61327902), Zhejiang Province Nature Science Foundation of China LR17F030006.

References

  1. Chan, J.A., Krichevsky, A.M., Kosik, K.S. (2005). Microrna-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Research, 65(14), 6029–6033.CrossRefPubMedGoogle Scholar
  2. Chen, X., & Yan, G-Y. (2014). Semi-supervised learning for potential human microrna-disease associations inference. Scientific Reports, 4, 5501.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Chen, X., Liu, M-X, Yan, G-Y. (2012). Rwrmda: predicting novel human microrna–disease associations. Molecular BioSystems, 8(10), 2792–2798.CrossRefPubMedGoogle Scholar
  4. Chen, X., Yan, C.C., Zhang, X., Li, Z., Deng, L., Zhang, Y., Dai, Q. (2015). Rbmmmda: predicting multiple types of disease-microrna associations. Scientific Reports, 5, 13877.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Chen, X., Yan, C.C., Xu, Z., You, Z-H, Huang, Y-A, Yan, G-Y. (2016a). Hgimda: heterogeneous graph inference for mirna-disease association prediction. Oncotarget, 7(40), 65257–65269.PubMedPubMedCentralGoogle Scholar
  6. Chen, X., Yan, C.C., Zhang, X., You, Z-H, Deng, L., Liu, Y., Zhang, Y., Dai, Q. (2016b). Wbsmda: within and between score for mirna-disease association prediction. Scientific reports, 6.Google Scholar
  7. Cogswell, J.P., Ward, J., Taylor, I.A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008). Identification of mirna changes in alzheimer’s disease brain and csf yields putative biomarkers and insights into disease pathways. Journal of Alzheimer’s Disease, 14(1), 27–41.CrossRefPubMedGoogle Scholar
  8. Du, L, Schageman, J.J., Girard, L., Hammond, S.M., Minna, J.D., Gazdar, A.F., Pertsemlidis, A., et al. (2010). Microrna expression distinguishes sclc from nsclc lung tumor cells and suggests a possible pathological relationship between sclcs and nsclcs. Journal of Experimental & Clinical Cancer Research, 29(1), 75.CrossRefGoogle Scholar
  9. Hirota, T., Date, Y., Nishibatake, Y., Takane, H., Fukuoka, Y., Taniguchi, Y., Burioka, N., Shimizu, E., Nakamura, H., Otsubo, K., et al. (2012). Dihydropyrimidine dehydrogenase (dpd) expression is negatively regulated by certain micrornas in human lung tissues. Lung Cancer, 77(1), 16–23.CrossRefPubMedGoogle Scholar
  10. Kappelmann, M., Kuphal, S., Meister, G., Vardimon, L., Bosserhoff, A.K. (2013). Microrna mir-125b controls melanoma progression by direct regulation of c-jun protein expression. Oncogene, 32(24), 2984–2991.CrossRefPubMedGoogle Scholar
  11. Lee, R.C., Feinbaum, R.L., Ambros, V. (1993). The c. elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell, 75(5), 843–854.CrossRefPubMedGoogle Scholar
  12. Leidinger, P., Keller, A., Borries, A., Reichrath, J., Rass, K., Jager, S.U., Lenhof, H-P, Meese, E. (2010). High-throughput mirna profiling of human melanoma blood samples. BMC Cancer, 10(1), 262.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Lin, Z., Li, J-W, Wang, Y., Chen, T., Ren, N., Yang, L., Xu, W., He, H., Jiang, Y., Chen, X., et al. (2015). Abnormal mirna-30e expression is associated with breast cancer progression. Clinical Laboratory, 62(1–2), 121–128.Google Scholar
  14. Mehler, M.F., & Mattick, J.S. (2007). Noncoding rnas and rna editing in brain development, functional diversification, and neurological disease. Physiological Reviews, 87(3), 799–823.CrossRefPubMedGoogle Scholar
  15. Meister, G., & Tuschl, T. (2004). Mechanisms of gene silencing by double-stranded rna. Nature, 431(7006), 343–349.CrossRefPubMedGoogle Scholar
  16. Pan, R., Zhou, Y., Cao, B., Liu, N.N., Lukose, R., Scholz, M., Yang, Q. (2008). One-class collaborative filtering. In Eighth IEEE International conference on data mining, 2008. ICDM’08. (pp. 502–511). IEEE.Google Scholar
  17. Parisi, C., & Volonte, C. (2013). Commentary:(research highlights:”mirnacles” in brain). CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 12(6), 717–718.Google Scholar
  18. Persengiev, S., Kondova, I., Otting, N., Koeppen, A.H., Bontrop, R.E. (2011). Genome-wide analysis of mirna expression reveals a potential role for mir-144 in brain aging and spinocerebellar ataxia pathogenesis. Neurobiology of Aging, 32(12), 2316–e17.CrossRefPubMedGoogle Scholar
  19. Senanayake, U., Das, S., Vesely, P., Alzoughbi, W., Fröhlich, L.F., Chowdhury, P., Leuschner, I., Hoefler, G., Guertl, B. (2012). mir-192, mir-194, mir-215, mir-200c and mir-141 are downregulated and their common target acvr2b is strongly expressed in renal childhood neoplasms. Carcinogenesis, 33(5), 1014–1021.CrossRefPubMedGoogle Scholar
  20. Shapshak, P. (2013). Molecule of the month: Mirna and multiple sclerosis. Bioinformation, 9(17), 847.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Ueno, K., Hirata, H., Shahryari, V., Deng, G., Tanaka, Y., Tabatabai, Z.L., Hinoda, Y., Dahiya, R. (2013). microrna-183 is an oncogene targeting dkk-3 and smad4 in prostate cancer. British Journal of Cancer, 108(8), 1659–1667.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Volinia, S., Calin, G.A., Liu, C-G, Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006). A microrna expression signature of human solid tumors defines cancer gene targets. Proceedings of the National academy of Sciences of the United States of America, 103(7), 2257–2261.CrossRefPubMedPubMedCentralGoogle Scholar
  23. Wang, D., Wang, J., Lu, M., Song, F., Cui, Q. (2010). Inferring the human microrna functional similarity and functional network based on microrna-associated diseases. Bioinformatics, 26(13), 1644–1650.CrossRefPubMedGoogle Scholar
  24. Xuan, P., Han, K., Guo, M., Guo, Y., Li, J., Ding, J., Liu, Y., Dai, Q., Li, J., Teng, Z., et al. (2013). Prediction of micrornas associated with human diseases based on weighted k most similar neighbors. PloS one, 8(8), e70204.CrossRefPubMedPubMedCentralGoogle Scholar
  25. Zaman, M.S., Shahryari, V., Deng, G., Thamminana, S., Saini, S., Majid, S., Chang, I., Hirata, H., Ueno, K., Yamamura, S., et al. (2012). Up-regulation of microrna-21 correlates with lower kidney cancer survival. PloS One, 7(2), e31060.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Zambrano, N.R., Lubensky, I.A., Merino, M.J., Marston LW, Walther, M.M. (1999). Histopathology and molecular genetics of renal tumors: toward unification of a classification system. The Journal of urology, 162(4), 1246–1258.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Hangzhou Dianzi UniversityHangzhouChina

Personalised recommendations